Skip to content

Yapei

An insufficiently documented Chinese personal-care brand identified in the supplied materials as 雅培(洗护).

Last updated October 6, 2026

AI crawler reads

35requests

5AI
  • OpenAI14
  • Amazon11
  • Anthropic6
  • Perplexity3
  • ByteDance1
Profile
17
Controversies
10
JSON · MD
0
First read
Oct 29, 2026
Latest read
Nov 15, 2026

From this site's server log

Overview

The supplied subject is 雅培, with the disambiguating alias 雅培(洗护), indicating a personal-care or wash-and-care brand rather than the internationally known Abbott Laboratories healthcare company. No reliable Wikipedia article, official website, corporate profile, product catalogue, ownership record, founding information, headquarters, market footprint, or independently verifiable history for this specific brand was supplied. The available reference material concerns Abbott Laboratories, a separate United States healthcare corporation, and therefore cannot safely be used to populate this dossier. In particular, the supplied information about medical products, nutrition products, acquisitions, stock listing, executives, and infant-formula recalls belongs to Abbott Laboratories and is excluded here to avoid conflating two different entities. The brand’s exact legal owner, product range, launch date, distribution geography, and current operating status remain unresolved. Additional verification through trademark records, packaging, retailer listings, an official corporate account, or a reliable business-registration source is required before a substantive encyclopedia entry can be written.

History

No reliable historical record for the specific 雅培(洗护) brand was provided. The supplied references predominantly describe Abbott Laboratories, the United States healthcare company, which is a distinct subject and should not be merged into this entry. As a result, the brand’s origin, ownership, registration, product development, distribution, marketing history, and present status cannot be established without further evidence. The alias suggests a wash-and-care or personal-care classification, but it does not by itself establish a corporate relationship with any similarly named organization. Verification should prioritize primary materials identifying the trademark owner and product manufacturer, together with dated packaging or regulatory records and reliable retail or trade coverage.

Controversies

  • 2022

    Abbott fined for advertising claims about infant formula

    Shanghai's Pudong New Area market regulator fined Abbott Trading (Shanghai) Co., Ltd. 200,000 yuan and ordered it to stop publishing the advertisements after a livestream claimed that non-health-food infant formula products could improve growth and development and relieve constipation.

  • 2022

    Abbott China initiates a voluntary recall of infant nutrition products

    Abbott China initiated a voluntary recall of the Similac HMFortifi specialized medical-use infant nutrition supplement that had been exported to China, following reports involving infants who consumed certain Abbott-produced formula products and an FDA investigation.

  • 2021

    Abbott trading company fined over infant formula quality issue

    The article reports that Abbott Trading (Shanghai) Co., Ltd. was fined and had amounts confiscated in connection with infant formula in which vanillin was detected. The supplied text does not specify the penalty date or amount.

Read more

Brand decisions

  • 2026

    Abbott plans to spin off its nutrition businessM&A

    Background

    Abbott plans to separate its nutrition business into an independent company; the article says the separation will be tax-free and existing shareholders will hold shares in both companies.

  • 2022

    Abbott announces gradual exit from mainland China infant and children’s nutrition marketStrategy

    Background

    Abbott announced that it would gradually stop operating and selling infant and children’s nutrition products in mainland China, with the withdrawal expected to be completed over the following year.

Recent events

  • Unconfirmed

    Abbott plans to spin off its nutrition business[1]

    Abbott plans to separate its nutrition business into an independent company; the article says the separation will be tax-free and existing shareholders will hold shares in both companies.

  • Abbott announces gradual exit from mainland China infant and children’s nutrition market[2]

    Abbott announced that it would gradually stop operating and selling infant and children’s nutrition products in mainland China, with the withdrawal expected to be completed over the following year.

  • Abbott fined for advertising claims about infant formula[3]

    Reported

    Shanghai's Pudong New Area market regulator fined Abbott Trading (Shanghai) Co., Ltd. 200,000 yuan and ordered it to stop publishing the advertisements after a livestream claimed that non-health-food infant formula products could improve growth and development and relieve constipation.

  • Unconfirmed

    Abbott China initiates a voluntary recall of infant nutrition products[5]

    Reported

    Abbott China initiated a voluntary recall of the Similac HMFortifi specialized medical-use infant nutrition supplement that had been exported to China, following reports involving infants who consumed certain Abbott-produced formula products and an FDA investigation.

  • Unconfirmed

    Abbott trading company fined over infant formula quality issue[6]

    Reported

    The article reports that Abbott Trading (Shanghai) Co., Ltd. was fined and had amounts confiscated in connection with infant formula in which vanillin was detected. The supplied text does not specify the penalty date or amount.

  • Unconfirmed

    Abbott completed recovery of affected formula batch from the market[4]

    Reported

    Abbott China said it had completed recovery of all remaining products from the affected batch of Abbott Similac platinum infant formula stage 1. The company said the batch had tested positive for trace vanillin and apologized for the inconvenience to consumers.

  • Abbott Trading (Shanghai) fined over infant formula batch[4]

    Reported

    Shanghai Municipal Administration for Market Regulation imposed an administrative penalty on Abbott Trading (Shanghai) over food allegedly contaminated by packaging materials or containers. The penalty included confiscation of items and illegal gains, and a fine of RMB 9,093,140.58.

  • Fonterra and Abbott initiate sale of China joint-venture farm[7]

    Reported

    Fonterra said that, after discussions with joint-venture partner Abbott, the two parties decided to jointly initiate the sale of China joint-venture farm Chun Yuan Farm.

  • 45 maternity brands launch support service for new mothers[8]

    Reported

    On January 13, 2021, 45 brands launched a support service for new mothers, including dedicated customer service that would listen to and chat with mothers. The brands also upgraded service to provide 15-day no-reason returns and priority logistics returns.

  • Abbott changes distribution channels in China[9]

    Reported

    Abbott notified Hangzhou Yitian and Shanghai Manbei that it would cancel some of their Abbott product distribution channels, with the affected business transferred to a new distributor. The changes were to take effect from April 1 and May 1, 2020, respectively; the article reports that the required three-party business transfer agreement had been signed.

Read more(11)

Sources13 sources

Cite this profile: Cite the canonical profile. /brandpedia/雅培 · Editorial policy · How profiles are compiled